BackMersana Therapeutics Overview

Mersana Therapeutics Receivables

Track Mersana Therapeutics's receivables ($170K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$168000.00
↓ 83.20% YoYΔ $-832000.00 vs prior year quarter

Peer average / median

Loading

Mersana Therapeutics Receivables History

Loading

Mersana Therapeutics vs. peers: Receivables Comparison

Loading

Mersana Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Mersana Therapeutics (MRSN) FAQ

Mersana Therapeutics (MRSN) currently reports a receivables of $170K as of September 2025. That compares with $1M in the prior-year period — down 83.2% year over year. Use the charts on this page to explore Mersana Therapeutics's receivables history and peer comparisons.

Mersana Therapeutics's receivables decreased from $1M to $170K — a 83.2% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Mersana Therapeutics reported $170K in receivables as of September 2025. That compares with $1M in the prior-year period — down 83.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $170K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Mersana Therapeutics, and consider following MRSN for alerts when major investors trade the stock.

Mersana Therapeutics is classified in the Healthcare sector. On receivables, it currently shows $170K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MRSN with unrelated industries.